Global Gene Therapy in Oncology Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
LPI (LP Information)' newest research report, the “Gene Therapy in Oncology Industry Forecast” looks at past sales and reviews total world Gene Therapy in Oncology sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Oncology sales for 2023 through 2029. With Gene Therapy in Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Oncology industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy in Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Oncology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Oncology.
The global Gene Therapy in Oncology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy in Oncology players cover Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine and Geron Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Oncology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
LPI (LP Information)' newest research report, the “Gene Therapy in Oncology Industry Forecast” looks at past sales and reviews total world Gene Therapy in Oncology sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Oncology sales for 2023 through 2029. With Gene Therapy in Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Oncology industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy in Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Oncology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Oncology.
The global Gene Therapy in Oncology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy in Oncology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy in Oncology players cover Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine and Geron Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Oncology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Ex Vivo
- In Vivo
- Hospitals
- Diagnostics Centers
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Cold Genesys
- Advantagene
- Amgen
- AstraZeneca
- Bio-Path Holdings
- CRISPR Therapeutics
- Editas Medicine
- Geron Corp
- Idera Pharmaceuticals
- Intellia Therapeutics
- Johnson & Johnson
- Marsala Biotech
- Merck
- Mologen AG
- Oncolytics Biotech
- Oncosec
- Oncotelic
- Shenzhen SiBiono GeneTech
- Sillajen Biotherapeutics
- Tocagen
- UniQure
- Ziopharm Oncology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size 2018-2029
2.1.2 Gene Therapy in Oncology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy in Oncology Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy in Oncology Market Size by Type
2.3.1 Gene Therapy in Oncology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy in Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Gene Therapy in Oncology Market Size by Application
2.5.1 Gene Therapy in Oncology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
3 GENE THERAPY IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Gene Therapy in Oncology Market Size Market Share by Players
3.1.1 Global Gene Therapy in Oncology Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY BY REGIONS
4.1 Gene Therapy in Oncology Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy in Oncology Market Size Growth (2018-2023)
4.3 APAC Gene Therapy in Oncology Market Size Growth (2018-2023)
4.4 Europe Gene Therapy in Oncology Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy in Oncology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy in Oncology Market Size by Country (2018-2023)
5.2 Americas Gene Therapy in Oncology Market Size by Type (2018-2023)
5.3 Americas Gene Therapy in Oncology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Oncology Market Size by Region (2018-2023)
6.2 APAC Gene Therapy in Oncology Market Size by Type (2018-2023)
6.3 APAC Gene Therapy in Oncology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Oncology by Country (2018-2023)
7.2 Europe Gene Therapy in Oncology Market Size by Type (2018-2023)
7.3 Europe Gene Therapy in Oncology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Oncology by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN ONCOLOGY MARKET FORECAST
10.1 Global Gene Therapy in Oncology Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy in Oncology Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy in Oncology Forecast
10.1.3 APAC Gene Therapy in Oncology Forecast
10.1.4 Europe Gene Therapy in Oncology Forecast
10.1.5 Middle East & Africa Gene Therapy in Oncology Forecast
10.2 Americas Gene Therapy in Oncology Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy in Oncology Market Forecast
10.2.2 Canada Gene Therapy in Oncology Market Forecast
10.2.3 Mexico Gene Therapy in Oncology Market Forecast
10.2.4 Brazil Gene Therapy in Oncology Market Forecast
10.3 APAC Gene Therapy in Oncology Forecast by Region (2024-2029)
10.3.1 China Gene Therapy in Oncology Market Forecast
10.3.2 Japan Gene Therapy in Oncology Market Forecast
10.3.3 Korea Gene Therapy in Oncology Market Forecast
10.3.4 Southeast Asia Gene Therapy in Oncology Market Forecast
10.3.5 India Gene Therapy in Oncology Market Forecast
10.3.6 Australia Gene Therapy in Oncology Market Forecast
10.4 Europe Gene Therapy in Oncology Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy in Oncology Market Forecast
10.4.2 France Gene Therapy in Oncology Market Forecast
10.4.3 UK Gene Therapy in Oncology Market Forecast
10.4.4 Italy Gene Therapy in Oncology Market Forecast
10.4.5 Russia Gene Therapy in Oncology Market Forecast
10.5 Middle East & Africa Gene Therapy in Oncology Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy in Oncology Market Forecast
10.5.2 South Africa Gene Therapy in Oncology Market Forecast
10.5.3 Israel Gene Therapy in Oncology Market Forecast
10.5.4 Turkey Gene Therapy in Oncology Market Forecast
10.5.5 GCC Countries Gene Therapy in Oncology Market Forecast
10.6 Global Gene Therapy in Oncology Forecast by Type (2024-2029)
10.7 Global Gene Therapy in Oncology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Cold Genesys
11.2.1 Cold Genesys Company Information
11.2.2 Cold Genesys Gene Therapy in Oncology Product Offered
11.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cold Genesys Main Business Overview
11.2.5 Cold Genesys Latest Developments
11.3 Advantagene
11.3.1 Advantagene Company Information
11.3.2 Advantagene Gene Therapy in Oncology Product Offered
11.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Advantagene Main Business Overview
11.3.5 Advantagene Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Gene Therapy in Oncology Product Offered
11.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Gene Therapy in Oncology Product Offered
11.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Information
11.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Offered
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Path Holdings Main Business Overview
11.6.5 Bio-Path Holdings Latest Developments
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Information
11.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Offered
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CRISPR Therapeutics Main Business Overview
11.7.5 CRISPR Therapeutics Latest Developments
11.8 Editas Medicine
11.8.1 Editas Medicine Company Information
11.8.2 Editas Medicine Gene Therapy in Oncology Product Offered
11.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Editas Medicine Main Business Overview
11.8.5 Editas Medicine Latest Developments
11.9 Geron Corp
11.9.1 Geron Corp Company Information
11.9.2 Geron Corp Gene Therapy in Oncology Product Offered
11.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Geron Corp Main Business Overview
11.9.5 Geron Corp Latest Developments
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Information
11.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Idera Pharmaceuticals Main Business Overview
11.10.5 Idera Pharmaceuticals Latest Developments
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Information
11.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Offered
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Intellia Therapeutics Main Business Overview
11.11.5 Intellia Therapeutics Latest Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Information
11.12.2 Johnson & Johnson Gene Therapy in Oncology Product Offered
11.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Johnson & Johnson Main Business Overview
11.12.5 Johnson & Johnson Latest Developments
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Information
11.13.2 Marsala Biotech Gene Therapy in Oncology Product Offered
11.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Marsala Biotech Main Business Overview
11.13.5 Marsala Biotech Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Gene Therapy in Oncology Product Offered
11.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mologen AG
11.15.1 Mologen AG Company Information
11.15.2 Mologen AG Gene Therapy in Oncology Product Offered
11.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Mologen AG Main Business Overview
11.15.5 Mologen AG Latest Developments
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Information
11.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Offered
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Oncolytics Biotech Main Business Overview
11.16.5 Oncolytics Biotech Latest Developments
11.17 Oncosec
11.17.1 Oncosec Company Information
11.17.2 Oncosec Gene Therapy in Oncology Product Offered
11.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Oncosec Main Business Overview
11.17.5 Oncosec Latest Developments
11.18 Oncotelic
11.18.1 Oncotelic Company Information
11.18.2 Oncotelic Gene Therapy in Oncology Product Offered
11.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Oncotelic Main Business Overview
11.18.5 Oncotelic Latest Developments
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Information
11.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Shenzhen SiBiono GeneTech Main Business Overview
11.19.5 Shenzhen SiBiono GeneTech Latest Developments
11.20 Sillajen Biotherapeutics
11.20.1 Sillajen Biotherapeutics Company Information
11.20.2 Sillajen Biotherapeutics Gene Therapy in Oncology Product Offered
11.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Sillajen Biotherapeutics Main Business Overview
11.20.5 Sillajen Biotherapeutics Latest Developments
11.21 Tocagen
11.21.1 Tocagen Company Information
11.21.2 Tocagen Gene Therapy in Oncology Product Offered
11.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Tocagen Main Business Overview
11.21.5 Tocagen Latest Developments
11.22 UniQure
11.22.1 UniQure Company Information
11.22.2 UniQure Gene Therapy in Oncology Product Offered
11.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 UniQure Main Business Overview
11.22.5 UniQure Latest Developments
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Information
11.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Offered
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Ziopharm Oncology Main Business Overview
11.23.5 Ziopharm Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size 2018-2029
2.1.2 Gene Therapy in Oncology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy in Oncology Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy in Oncology Market Size by Type
2.3.1 Gene Therapy in Oncology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy in Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Gene Therapy in Oncology Market Size by Application
2.5.1 Gene Therapy in Oncology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
3 GENE THERAPY IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Gene Therapy in Oncology Market Size Market Share by Players
3.1.1 Global Gene Therapy in Oncology Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY BY REGIONS
4.1 Gene Therapy in Oncology Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy in Oncology Market Size Growth (2018-2023)
4.3 APAC Gene Therapy in Oncology Market Size Growth (2018-2023)
4.4 Europe Gene Therapy in Oncology Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy in Oncology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy in Oncology Market Size by Country (2018-2023)
5.2 Americas Gene Therapy in Oncology Market Size by Type (2018-2023)
5.3 Americas Gene Therapy in Oncology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Oncology Market Size by Region (2018-2023)
6.2 APAC Gene Therapy in Oncology Market Size by Type (2018-2023)
6.3 APAC Gene Therapy in Oncology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Oncology by Country (2018-2023)
7.2 Europe Gene Therapy in Oncology Market Size by Type (2018-2023)
7.3 Europe Gene Therapy in Oncology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Oncology by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN ONCOLOGY MARKET FORECAST
10.1 Global Gene Therapy in Oncology Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy in Oncology Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy in Oncology Forecast
10.1.3 APAC Gene Therapy in Oncology Forecast
10.1.4 Europe Gene Therapy in Oncology Forecast
10.1.5 Middle East & Africa Gene Therapy in Oncology Forecast
10.2 Americas Gene Therapy in Oncology Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy in Oncology Market Forecast
10.2.2 Canada Gene Therapy in Oncology Market Forecast
10.2.3 Mexico Gene Therapy in Oncology Market Forecast
10.2.4 Brazil Gene Therapy in Oncology Market Forecast
10.3 APAC Gene Therapy in Oncology Forecast by Region (2024-2029)
10.3.1 China Gene Therapy in Oncology Market Forecast
10.3.2 Japan Gene Therapy in Oncology Market Forecast
10.3.3 Korea Gene Therapy in Oncology Market Forecast
10.3.4 Southeast Asia Gene Therapy in Oncology Market Forecast
10.3.5 India Gene Therapy in Oncology Market Forecast
10.3.6 Australia Gene Therapy in Oncology Market Forecast
10.4 Europe Gene Therapy in Oncology Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy in Oncology Market Forecast
10.4.2 France Gene Therapy in Oncology Market Forecast
10.4.3 UK Gene Therapy in Oncology Market Forecast
10.4.4 Italy Gene Therapy in Oncology Market Forecast
10.4.5 Russia Gene Therapy in Oncology Market Forecast
10.5 Middle East & Africa Gene Therapy in Oncology Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy in Oncology Market Forecast
10.5.2 South Africa Gene Therapy in Oncology Market Forecast
10.5.3 Israel Gene Therapy in Oncology Market Forecast
10.5.4 Turkey Gene Therapy in Oncology Market Forecast
10.5.5 GCC Countries Gene Therapy in Oncology Market Forecast
10.6 Global Gene Therapy in Oncology Forecast by Type (2024-2029)
10.7 Global Gene Therapy in Oncology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Cold Genesys
11.2.1 Cold Genesys Company Information
11.2.2 Cold Genesys Gene Therapy in Oncology Product Offered
11.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cold Genesys Main Business Overview
11.2.5 Cold Genesys Latest Developments
11.3 Advantagene
11.3.1 Advantagene Company Information
11.3.2 Advantagene Gene Therapy in Oncology Product Offered
11.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Advantagene Main Business Overview
11.3.5 Advantagene Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Gene Therapy in Oncology Product Offered
11.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Gene Therapy in Oncology Product Offered
11.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Information
11.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Offered
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Path Holdings Main Business Overview
11.6.5 Bio-Path Holdings Latest Developments
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Information
11.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Offered
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CRISPR Therapeutics Main Business Overview
11.7.5 CRISPR Therapeutics Latest Developments
11.8 Editas Medicine
11.8.1 Editas Medicine Company Information
11.8.2 Editas Medicine Gene Therapy in Oncology Product Offered
11.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Editas Medicine Main Business Overview
11.8.5 Editas Medicine Latest Developments
11.9 Geron Corp
11.9.1 Geron Corp Company Information
11.9.2 Geron Corp Gene Therapy in Oncology Product Offered
11.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Geron Corp Main Business Overview
11.9.5 Geron Corp Latest Developments
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Information
11.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Idera Pharmaceuticals Main Business Overview
11.10.5 Idera Pharmaceuticals Latest Developments
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Information
11.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Offered
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Intellia Therapeutics Main Business Overview
11.11.5 Intellia Therapeutics Latest Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Information
11.12.2 Johnson & Johnson Gene Therapy in Oncology Product Offered
11.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Johnson & Johnson Main Business Overview
11.12.5 Johnson & Johnson Latest Developments
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Information
11.13.2 Marsala Biotech Gene Therapy in Oncology Product Offered
11.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Marsala Biotech Main Business Overview
11.13.5 Marsala Biotech Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Gene Therapy in Oncology Product Offered
11.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mologen AG
11.15.1 Mologen AG Company Information
11.15.2 Mologen AG Gene Therapy in Oncology Product Offered
11.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Mologen AG Main Business Overview
11.15.5 Mologen AG Latest Developments
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Information
11.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Offered
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Oncolytics Biotech Main Business Overview
11.16.5 Oncolytics Biotech Latest Developments
11.17 Oncosec
11.17.1 Oncosec Company Information
11.17.2 Oncosec Gene Therapy in Oncology Product Offered
11.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Oncosec Main Business Overview
11.17.5 Oncosec Latest Developments
11.18 Oncotelic
11.18.1 Oncotelic Company Information
11.18.2 Oncotelic Gene Therapy in Oncology Product Offered
11.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Oncotelic Main Business Overview
11.18.5 Oncotelic Latest Developments
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Information
11.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Shenzhen SiBiono GeneTech Main Business Overview
11.19.5 Shenzhen SiBiono GeneTech Latest Developments
11.20 Sillajen Biotherapeutics
11.20.1 Sillajen Biotherapeutics Company Information
11.20.2 Sillajen Biotherapeutics Gene Therapy in Oncology Product Offered
11.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Sillajen Biotherapeutics Main Business Overview
11.20.5 Sillajen Biotherapeutics Latest Developments
11.21 Tocagen
11.21.1 Tocagen Company Information
11.21.2 Tocagen Gene Therapy in Oncology Product Offered
11.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Tocagen Main Business Overview
11.21.5 Tocagen Latest Developments
11.22 UniQure
11.22.1 UniQure Company Information
11.22.2 UniQure Gene Therapy in Oncology Product Offered
11.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 UniQure Main Business Overview
11.22.5 UniQure Latest Developments
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Information
11.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Offered
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Ziopharm Oncology Main Business Overview
11.23.5 Ziopharm Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy in Oncology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Ex Vivo
Table 3. Major Players of In Vivo
Table 4. Gene Therapy in Oncology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy in Oncology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy in Oncology Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy in Oncology Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy in Oncology Key Players Head office and Products Offered
Table 13. Gene Therapy in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy in Oncology Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy in Oncology Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy in Oncology Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy in Oncology Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy in Oncology Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy in Oncology Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy in Oncology Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy in Oncology Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy in Oncology Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy in Oncology Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy in Oncology
Table 45. Key Market Challenges & Risks of Gene Therapy in Oncology
Table 46. Key Industry Trends of Gene Therapy in Oncology
Table 47. Global Gene Therapy in Oncology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy in Oncology Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy in Oncology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy in Oncology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Bristol-Myers Squibb Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 52. Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
Table 53. Bristol-Myers Squibb Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Bristol-Myers Squibb Main Business
Table 55. Bristol-Myers Squibb Latest Developments
Table 56. Cold Genesys Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 57. Cold Genesys Gene Therapy in Oncology Product Offered
Table 58. Cold Genesys Main Business
Table 59. Cold Genesys Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cold Genesys Latest Developments
Table 61. Advantagene Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 62. Advantagene Gene Therapy in Oncology Product Offered
Table 63. Advantagene Main Business
Table 64. Advantagene Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Advantagene Latest Developments
Table 66. Amgen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 67. Amgen Gene Therapy in Oncology Product Offered
Table 68. Amgen Main Business
Table 69. Amgen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Amgen Latest Developments
Table 71. AstraZeneca Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 72. AstraZeneca Gene Therapy in Oncology Product Offered
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. AstraZeneca Latest Developments
Table 76. Bio-Path Holdings Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 77. Bio-Path Holdings Gene Therapy in Oncology Product Offered
Table 78. Bio-Path Holdings Main Business
Table 79. Bio-Path Holdings Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bio-Path Holdings Latest Developments
Table 81. CRISPR Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 82. CRISPR Therapeutics Gene Therapy in Oncology Product Offered
Table 83. CRISPR Therapeutics Main Business
Table 84. CRISPR Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. CRISPR Therapeutics Latest Developments
Table 86. Editas Medicine Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 87. Editas Medicine Gene Therapy in Oncology Product Offered
Table 88. Editas Medicine Main Business
Table 89. Editas Medicine Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Editas Medicine Latest Developments
Table 91. Geron Corp Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 92. Geron Corp Gene Therapy in Oncology Product Offered
Table 93. Geron Corp Main Business
Table 94. Geron Corp Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Geron Corp Latest Developments
Table 96. Idera Pharmaceuticals Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 97. Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
Table 98. Idera Pharmaceuticals Main Business
Table 99. Idera Pharmaceuticals Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Idera Pharmaceuticals Latest Developments
Table 101. Intellia Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 102. Intellia Therapeutics Gene Therapy in Oncology Product Offered
Table 103. Intellia Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Intellia Therapeutics Main Business
Table 105. Intellia Therapeutics Latest Developments
Table 106. Johnson & Johnson Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 107. Johnson & Johnson Gene Therapy in Oncology Product Offered
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Johnson & Johnson Latest Developments
Table 111. Marsala Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 112. Marsala Biotech Gene Therapy in Oncology Product Offered
Table 113. Marsala Biotech Main Business
Table 114. Marsala Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Marsala Biotech Latest Developments
Table 116. Merck Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 117. Merck Gene Therapy in Oncology Product Offered
Table 118. Merck Main Business
Table 119. Merck Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Merck Latest Developments
Table 121. Mologen AG Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 122. Mologen AG Gene Therapy in Oncology Product Offered
Table 123. Mologen AG Main Business
Table 124. Mologen AG Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Mologen AG Latest Developments
Table 126. Oncolytics Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 127. Oncolytics Biotech Gene Therapy in Oncology Product Offered
Table 128. Oncolytics Biotech Main Business
Table 129. Oncolytics Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Oncolytics Biotech Latest Developments
Table 131. Oncosec Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 132. Oncosec Gene Therapy in Oncology Product Offered
Table 133. Oncosec Main Business
Table 134. Oncosec Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Oncosec Latest Developments
Table 136. Oncotelic Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 137. Oncotelic Gene Therapy in Oncology Product Offered
Table 138. Oncotelic Main Business
Table 139. Oncotelic Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Oncotelic Latest Developments
Table 141. Shenzhen SiBiono GeneTech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 142. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
Table 143. Shenzhen SiBiono GeneTech Main Business
Table 144. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Shenzhen SiBiono GeneTech Latest Developments
Table 146. Sillajen Biotherapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 147. Sillajen Biotherapeutics Gene Therapy in Oncology Product Offered
Table 148. Sillajen Biotherapeutics Main Business
Table 149. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Sillajen Biotherapeutics Latest Developments
Table 151. Tocagen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 152. Tocagen Gene Therapy in Oncology Product Offered
Table 153. Tocagen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Tocagen Main Business
Table 155. Tocagen Latest Developments
Table 156. UniQure Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 157. UniQure Gene Therapy in Oncology Product Offered
Table 158. UniQure Main Business
Table 159. UniQure Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. UniQure Latest Developments
Table 161. Ziopharm Oncology Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 162. Ziopharm Oncology Gene Therapy in Oncology Product Offered
Table 163. Ziopharm Oncology Main Business
Table 164. Ziopharm Oncology Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. Ziopharm Oncology Latest Developments
Table 1. Gene Therapy in Oncology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Ex Vivo
Table 3. Major Players of In Vivo
Table 4. Gene Therapy in Oncology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy in Oncology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy in Oncology Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy in Oncology Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy in Oncology Key Players Head office and Products Offered
Table 13. Gene Therapy in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy in Oncology Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy in Oncology Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy in Oncology Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy in Oncology Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy in Oncology Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy in Oncology Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy in Oncology Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy in Oncology Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy in Oncology Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy in Oncology Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy in Oncology Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy in Oncology Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy in Oncology
Table 45. Key Market Challenges & Risks of Gene Therapy in Oncology
Table 46. Key Industry Trends of Gene Therapy in Oncology
Table 47. Global Gene Therapy in Oncology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy in Oncology Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy in Oncology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy in Oncology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Bristol-Myers Squibb Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 52. Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
Table 53. Bristol-Myers Squibb Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Bristol-Myers Squibb Main Business
Table 55. Bristol-Myers Squibb Latest Developments
Table 56. Cold Genesys Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 57. Cold Genesys Gene Therapy in Oncology Product Offered
Table 58. Cold Genesys Main Business
Table 59. Cold Genesys Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cold Genesys Latest Developments
Table 61. Advantagene Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 62. Advantagene Gene Therapy in Oncology Product Offered
Table 63. Advantagene Main Business
Table 64. Advantagene Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Advantagene Latest Developments
Table 66. Amgen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 67. Amgen Gene Therapy in Oncology Product Offered
Table 68. Amgen Main Business
Table 69. Amgen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Amgen Latest Developments
Table 71. AstraZeneca Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 72. AstraZeneca Gene Therapy in Oncology Product Offered
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. AstraZeneca Latest Developments
Table 76. Bio-Path Holdings Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 77. Bio-Path Holdings Gene Therapy in Oncology Product Offered
Table 78. Bio-Path Holdings Main Business
Table 79. Bio-Path Holdings Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bio-Path Holdings Latest Developments
Table 81. CRISPR Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 82. CRISPR Therapeutics Gene Therapy in Oncology Product Offered
Table 83. CRISPR Therapeutics Main Business
Table 84. CRISPR Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. CRISPR Therapeutics Latest Developments
Table 86. Editas Medicine Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 87. Editas Medicine Gene Therapy in Oncology Product Offered
Table 88. Editas Medicine Main Business
Table 89. Editas Medicine Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Editas Medicine Latest Developments
Table 91. Geron Corp Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 92. Geron Corp Gene Therapy in Oncology Product Offered
Table 93. Geron Corp Main Business
Table 94. Geron Corp Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Geron Corp Latest Developments
Table 96. Idera Pharmaceuticals Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 97. Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
Table 98. Idera Pharmaceuticals Main Business
Table 99. Idera Pharmaceuticals Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Idera Pharmaceuticals Latest Developments
Table 101. Intellia Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 102. Intellia Therapeutics Gene Therapy in Oncology Product Offered
Table 103. Intellia Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Intellia Therapeutics Main Business
Table 105. Intellia Therapeutics Latest Developments
Table 106. Johnson & Johnson Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 107. Johnson & Johnson Gene Therapy in Oncology Product Offered
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Johnson & Johnson Latest Developments
Table 111. Marsala Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 112. Marsala Biotech Gene Therapy in Oncology Product Offered
Table 113. Marsala Biotech Main Business
Table 114. Marsala Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Marsala Biotech Latest Developments
Table 116. Merck Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 117. Merck Gene Therapy in Oncology Product Offered
Table 118. Merck Main Business
Table 119. Merck Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Merck Latest Developments
Table 121. Mologen AG Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 122. Mologen AG Gene Therapy in Oncology Product Offered
Table 123. Mologen AG Main Business
Table 124. Mologen AG Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Mologen AG Latest Developments
Table 126. Oncolytics Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 127. Oncolytics Biotech Gene Therapy in Oncology Product Offered
Table 128. Oncolytics Biotech Main Business
Table 129. Oncolytics Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Oncolytics Biotech Latest Developments
Table 131. Oncosec Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 132. Oncosec Gene Therapy in Oncology Product Offered
Table 133. Oncosec Main Business
Table 134. Oncosec Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Oncosec Latest Developments
Table 136. Oncotelic Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 137. Oncotelic Gene Therapy in Oncology Product Offered
Table 138. Oncotelic Main Business
Table 139. Oncotelic Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Oncotelic Latest Developments
Table 141. Shenzhen SiBiono GeneTech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 142. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
Table 143. Shenzhen SiBiono GeneTech Main Business
Table 144. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Shenzhen SiBiono GeneTech Latest Developments
Table 146. Sillajen Biotherapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 147. Sillajen Biotherapeutics Gene Therapy in Oncology Product Offered
Table 148. Sillajen Biotherapeutics Main Business
Table 149. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Sillajen Biotherapeutics Latest Developments
Table 151. Tocagen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 152. Tocagen Gene Therapy in Oncology Product Offered
Table 153. Tocagen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Tocagen Main Business
Table 155. Tocagen Latest Developments
Table 156. UniQure Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 157. UniQure Gene Therapy in Oncology Product Offered
Table 158. UniQure Main Business
Table 159. UniQure Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. UniQure Latest Developments
Table 161. Ziopharm Oncology Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 162. Ziopharm Oncology Gene Therapy in Oncology Product Offered
Table 163. Ziopharm Oncology Main Business
Table 164. Ziopharm Oncology Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. Ziopharm Oncology Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Oncology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy in Oncology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy in Oncology Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy in Oncology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy in Oncology Market Size Market Share by Type in 2022
Figure 10. Gene Therapy in Oncology in Hospitals
Figure 11. Global Gene Therapy in Oncology Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Gene Therapy in Oncology in Diagnostics Centers
Figure 13. Global Gene Therapy in Oncology Market: Diagnostics Centers (2018-2023) & ($ Millions)
Figure 14. Gene Therapy in Oncology in Research Institutes
Figure 15. Global Gene Therapy in Oncology Market: Research Institutes (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy in Oncology Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy in Oncology Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy in Oncology Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy in Oncology Value Market Share by Country in 2022
Figure 24. United States Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy in Oncology Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy in Oncology Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy in Oncology Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy in Oncology Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy in Oncology Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy in Oncology Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene Therapy in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Oncology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy in Oncology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy in Oncology Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy in Oncology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy in Oncology Market Size Market Share by Type in 2022
Figure 10. Gene Therapy in Oncology in Hospitals
Figure 11. Global Gene Therapy in Oncology Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Gene Therapy in Oncology in Diagnostics Centers
Figure 13. Global Gene Therapy in Oncology Market: Diagnostics Centers (2018-2023) & ($ Millions)
Figure 14. Gene Therapy in Oncology in Research Institutes
Figure 15. Global Gene Therapy in Oncology Market: Research Institutes (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy in Oncology Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy in Oncology Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy in Oncology Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy in Oncology Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy in Oncology Value Market Share by Country in 2022
Figure 24. United States Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy in Oncology Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy in Oncology Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy in Oncology Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy in Oncology Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy in Oncology Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy in Oncology Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy in Oncology Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy in Oncology Market Size Market Share Forecast by Application (2024-2029)
